CCancer Immunology Immunotherapy3/18/2026Correction: Nattokinase-driven remodeling of tumor microenvironment enhances the efficacy of MSLN-targeted CAR-T cell therapy in solid tumorsLei Zhao·Zhigang Guo·Tianyu Chen·Xinhao Yang·Y. Zhang·Jiaqi LiuRead at Cancer Immunology ImmunotherapyTagsCAR-T cell therapy researchOncology
